Endocrine Division, Harvard Vanguard Medical Associates, Boston, Massachusetts; Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Endocrinology and Metabolism Department, Regina Apostolorum Hospital, Albano, Rome, Italy.
Endocr Pract. 2021 Jul;27(7):649-660. doi: 10.1016/j.eprac.2021.04.007. Epub 2021 Jun 3.
The first edition of the American Association of Clinical Endocrinology/American College of Endocrinology/Associazione Medici Endocrinologi Guidelines for the Diagnosis and Management of Thyroid Nodules was published in 2006 and updated in 2010 and 2016. The American Association of Clinical Endocrinology/American College of Endocrinology/Associazione Medici Endocrinologi multidisciplinary thyroid nodules task force was charged with developing a novel interactive electronic algorithmic tool to evaluate thyroid nodules.
The Thyroid Nodule App (termed TNAPP) was based on the updated 2016 clinical practice guideline recommendations while incorporating recent scientific evidence and avoiding unnecessary diagnostic procedures and surgical overtreatment. This manuscript describes the algorithmic tool development, its data requirements, and its basis for decision making. It provides links to the web-based algorithmic tool and a tutorial.
TNAPP and TI-RADS were cross-checked on 95 thyroid nodules with histology-proven diagnoses.
TNAPP is a novel interactive web-based tool that uses clinical, imaging, cytologic, and molecular marker data to guide clinical decision making to evaluate and manage thyroid nodules. It may be used as a heuristic tool for evaluating and managing patients with thyroid nodules. It can be adapted to create registries for solo practices, large multispecialty delivery systems, regional and national databases, and research consortiums. Prospective studies are underway to validate TNAPP to determine how it compares with other ultrasound-based classification systems and whether it can improve the care of patients with clinically significant thyroid nodules while reducing the substantial burden incurred by those who do not benefit from further evaluation and treatment.
美国临床内分泌医师协会/美国内分泌医师学会/意大利内分泌医师协会《甲状腺结节诊治指南》第一版于 2006 年发布,2010 年和 2016 年进行了更新。美国临床内分泌医师协会/美国内分泌医师学会/意大利内分泌医师协会多学科甲状腺结节工作组负责开发一种新的交互式电子算法工具来评估甲状腺结节。
甲状腺结节应用程序(简称 TNAPP)是基于 2016 年更新的临床实践指南建议,同时纳入了最新的科学证据,避免了不必要的诊断程序和过度手术治疗。本文档描述了算法工具的开发、数据要求及其决策依据。它提供了基于网络的算法工具和教程的链接。
TNAPP 和 TI-RADS 在 95 个有组织学诊断的甲状腺结节上进行了交叉核对。
TNAPP 是一种新的交互式网络工具,它使用临床、影像、细胞学和分子标志物数据来指导临床决策,以评估和管理甲状腺结节。它可以作为评估和管理甲状腺结节患者的启发式工具。它可以适用于创建单人实践、大型多专科交付系统、区域和国家数据库以及研究联盟的登记处。正在进行前瞻性研究以验证 TNAPP,以确定其与其他基于超声的分类系统相比如何,以及它是否可以改善有临床意义的甲状腺结节患者的护理,同时减少那些从进一步评估和治疗中获益的患者的负担。